Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
China Sky One Medical has asked the SFDA to approve...
Sanofi-Aventis will acquire BMP Sunstone for $520...
China Sky One...
Simcere will develop a cardiovascular molecule with...
China Sky One Medical, Inc. reported it received SFDA...
Bridge Labs announced the FDA accepted its...
It's earnings season, and almost every day for the past...
China Sky One Medical, with its near-constant barrage of...
Although the ChinaBio® Index dropped during the...
Excel PharmaStudies of Beijing formed an alliance with...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
